ImmuCell Corp
NASDAQ:ICCC
ImmuCell Corp
NASDAQ:ICCC
Price:
4.88 USD
-10.89%
Updated:
May 16, 2024
ImmuCell Corp
EPS (Diluted)
|
ImmuCell Corp
EPS (Diluted) Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ImmuCell Corp
NASDAQ:ICCC
|
EPS (Diluted)
$0
|
CAGR 3-Years
-75%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
EPS (Diluted)
$2
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
EPS (Diluted)
$0
|
CAGR 3-Years
18%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-18%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
EPS (Diluted)
$7
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
1%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
EPS (Diluted)
$13
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
EPS (Diluted)
$33
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
25%
|
See Also
What is ImmuCell Corp's EPS (Diluted)?
EPS (Diluted)
-0.8
USD
-0.8
USD
Based on the financial report for Dec 31, 2023, ImmuCell Corp's EPS (Diluted) amounts to -0.8 USD.
What is ImmuCell Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-12%
-12%
Over the last year, the EPS (Diluted) growth was -134%. The average annual EPS (Diluted) growth rates for ImmuCell Corp have been -75% over the past three years , -12% over the past five years .
You don't have any saved screeners yet
